Literature DB >> 6440308

Discontinuous expression of a membrane antigen (HB-7) during B lymphocyte differentiation.

T F Tedder, L T Clement, M D Cooper.   

Abstract

We have examined the expression of a cell surface antigen by B lineage cells in human fetuses, newborns and adults using a newly produced monoclonal antibody, HB-7. The HB-7 antigen was found to be a protease sensitive 45,000 MW molecule that appeared to be the same molecule recognized by the OKT-10 antibody. The HB-7 reactive molecule was expressed by all fetal pre-B and B cells, and 50% of newborn blood and adult bone marrow B cells. In contrast, only a small minority of B cells (2-12%) from blood, spleen and tonsil of adults were weakly HB-7+. The pokeweed mitogen-responsive B cell precursors of plasma cells were also HB-7-, but the HB-7 antigen was re-expressed during the plasma cell stage. We conclude that this antigen is unique among known B cell differentiation antigens in its intermittent pattern of expression during B cell development. The reactivity of the HB-7 antibody with immature, but not mature, B cells makes it well suited for studies of B cell ontogeny.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6440308     DOI: 10.1111/j.1399-0039.1984.tb02118.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  11 in total

1.  The HB-6, CDw75, and CD76 differentiation antigens are unique cell-surface carbohydrate determinants generated by the beta-galactoside alpha 2,6-sialyltransferase.

Authors:  B J Bast; L J Zhou; G J Freeman; K J Colley; T J Ernst; J M Munro; T F Tedder
Journal:  J Cell Biol       Date:  1992-01       Impact factor: 10.539

2.  Precursor B cells transformed by Epstein-Barr virus undergo sterile plasma-cell differentiation: J-chain expression without immunoglobulin.

Authors:  H Kubagawa; P D Burrows; C E Grossi; J Mestecky; M D Cooper
Journal:  Proc Natl Acad Sci U S A       Date:  1988-02       Impact factor: 11.205

3.  The role of receptors for complement in the induction of polyclonal B-cell proliferation and differentiation.

Authors:  T F Tedder; J J Weis; L T Clement; D T Fearon; M D Cooper
Journal:  J Clin Immunol       Date:  1986-01       Impact factor: 8.317

4.  Bare lymphocyte syndrome. Consequences of absent class II major histocompatibility antigen expression for B lymphocyte differentiation and function.

Authors:  L T Clement; S Plaeger-Marshall; A Haas; A Saxon; A M Martin
Journal:  J Clin Invest       Date:  1988-03       Impact factor: 14.808

5.  Burkitt's lymphoma is a malignancy of mature B cells expressing somatically mutated V region genes.

Authors:  U Klein; G Klein; B Ehlin-Henriksson; K Rajewsky; R Küppers
Journal:  Mol Med       Date:  1995-07       Impact factor: 6.354

6.  Identification and characterization of circulating human transitional B cells.

Authors:  Gary P Sims; Rachel Ettinger; Yuko Shirota; Cheryl H Yarboro; Gabor G Illei; Peter E Lipsky
Journal:  Blood       Date:  2005-02-08       Impact factor: 22.113

7.  Novel type of proliferating lymphoplasmacytoid cell with a characteristic spotted immunofluorescence pattern.

Authors:  H M Lokhorst; S E Boom; B J Bast; P J Peters; T F Tedder; J Gerdes; E Petersen; R E Ballieux
Journal:  J Clin Invest       Date:  1987-05       Impact factor: 14.808

Review 8.  The Role of Long-Lived Plasma Cells in Antibody-Mediated Rejection of Kidney Transplantation: An Update.

Authors:  Hua Su; Chun-Yun Zhang; Ji-Hong Lin; Hans-Peter Hammes; Chun Zhang
Journal:  Kidney Dis (Basel)       Date:  2019-08-20

9.  Identification of the sequence required for expression of the 2H4 epitope on the human leukocyte common antigens.

Authors:  M Streuli; T Matsuyama; C Morimoto; S F Schlossman; H Saito
Journal:  J Exp Med       Date:  1987-11-01       Impact factor: 14.307

10.  Retinoic acid induces the differentiation of B cell hybridomas from patients with common variable immunodeficiency.

Authors:  E Sherr; D C Adelman; A Saxon; M Gilly; R Wall; N Sidell
Journal:  J Exp Med       Date:  1988-07-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.